Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) EBT: 2009-2011

Historic EBT for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to -$33.8 million.

  • Lexicon Pharmaceuticals' EBT fell 47.16% to -$33.8 million in Q4 2011 from the same period last year, while for Dec 2011 it was -$115.1 million, marking a year-over-year decrease of 16.03%. This contributed to the annual value of -$116.2 million for FY2011, which is 14.16% down from last year.
  • As of Q4 2011, Lexicon Pharmaceuticals' EBT stood at -$33.8 million, which was down 29.66% from -$26.1 million recorded in Q3 2011.
  • Over the past 5 years, Lexicon Pharmaceuticals' EBT peaked at -$20.9 million during Q3 2009, and registered a low of -$33.8 million during Q4 2011.
  • For the 3-year period, Lexicon Pharmaceuticals' EBT averaged around -$25.4 million, with its median value being -$24.6 million (2010).
  • Data for Lexicon Pharmaceuticals' EBT shows a peak YoY increase of 5.21% (in 2011) and a maximum YoY decrease of 47.16% (in 2011) over the last 5 years.
  • Quarterly analysis of 3 years shows Lexicon Pharmaceuticals' EBT stood at -$21.8 million in 2009, then fell by 5.43% to -$23.0 million in 2010, then plummeted by 47.16% to -$33.8 million in 2011.
  • Its EBT stands at -$33.8 million for Q4 2011, versus -$26.1 million for Q3 2011 and -$26.7 million for Q2 2011.